Citigroup Ups ImClone Systems to Buy

Analyst Yaron Werber cites positive study data of Erbitux for head and neck cancer patients

Citigroup upgraded ImClone Systems (IMCL ) to buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.